Effects of fish cytochromes P450 inducers and inhibitors on difloxacin N-demethylation in kidney of Chinese idle (Ctenopharyngodon idellus)

Environmental Toxicology and Pharmacology

Volumn 29, Issue 3, 2010, Pages 202-208

  Yu, Ling Zhi ^a   Yang, Xian Le ^a  

^a SHANGHAI OCEAN UNIVERSITY   (China)

Author keywords

Cytochromes P450; Difloxacin; Induction; Inhibition; Kinetic

Indexed keywords

ALPHA NAPHTHOFLAVONE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; DIFLOXACIN; KETOCONAZOLE; N DEMETHYLASE; NORDIFLOXACIN; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMETHYLATION; DRUG STRUCTURE; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME METABOLISM; FISH; FISHERY MANAGEMENT; KIDNEY PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOXICOKINETICS;

CTENOPHARYNGODON IDELLA;

EID: 77951975668     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.11.008     Document Type: Article

References (51)

1. Aluru N., Vijayan M.M. Aryl hydrocarbon receptor activation impairs cortisol response to stress in rainbow trout by disrupting the rate-limiting steps in steroidogenesis. Endocrinology 2006, 147:1895-1903.
2. Bachmann K., He Y., Sarver J.G., Peng N. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes. Xenobiotica 2003, 33:265-276.
3. Bernhardt R. Optimized chimeragenesis; creating diverse P450 functions. Chem. Biol. 2004, 11:287-288.
4. Brausch J.M., Smith P.N. Mechanisms of resistance and cross-resistance to agrochemicals in the fairy shrimp Thamnocephalus platyurus (Crustacea: Anostraca). Aquat. Toxicol. 2009, 92:140-145.
5. Brouwers J.R. Drug interactions with quinolone antibacterials. Drug Saf. 1992, 7:268-281.
6. Browne E.P., Stapleton H.M., Kelly S.M., Tilton S.C., Gallagher E.P. In vitro hepatic metabolism of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE 99) in Chinook Salmon (Onchorhynchus tshawytscha). Aquat. Toxicol. 2009, 92:281-287.
7. Celander M., Förlin L. Catalytic activity and immunochemical quantification of hepatic cytochrome P-450 in β-naphthoflavone and isosafrol treated rainbow trout (Oncorhynchus mykiss). Fish Physiol. Biochem. 1991, 9:189-197.
8. Chung-Davidson Y.W., Rees C.B., Wu H., Yun S.S., Li W. Beta-naphthoflavone induction of CYP1A in brain of juvenile lake trout (Salvelinus namaycush Walbaum). J. Exp. Biol. 2004, 207:1533-1542.
9. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J. 1974, 137:143-144.
10. Ding F.K., Cao J.Y., Ma L.B., Pan Q.S., Fang Z.P., Lu X.C. Pharmacokinetics and tissue residues of difloxacin in crucian carp (Carassius auratus) after oral administration. Aquaculture 2006, 256:121-128.
11. Davies B.I., Maesen F.P. Drug interactions with quinolones. Rev. Infect. Dis. 1989, 11:S1083-1090.
12. Garcia M.A., Solans C., Aramayona J.J., Rueda S., Bregante M.A. Simultaneous determination of difloxacin and its primary metabolite sarafloxacin in rabbit plasma. Chromatographia 2000, 51:487-490.
13. 14C sarafloxacin hydrochloride from tissues of juvenile channel catfish (Ictalurus punctatus). Aquaculture 1995, 131:23-36.
14. Guengerich F.P. Cytochrome P450: what have we learned and what are the future issues?. Drug Metab. Rev. 2004, 36:159-197.
15. Gunawickrama S.H., Aarsaether N., Orbea A., Cajaraville M.P., Goksøyr A. PCB77 (3,3′,4,4′-tetrachlorobiphenyl) co-exposure prolongs CYP1A induction, and sustains oxidative stress in B(a)P-exposed turbot, Scophthalmus maximus, in a long-term study. Aquat. Toxicol. 2008, 89:65-74.
16. Harder S., Fuhr U., Staib A.H., Wolff T. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations. Am. J. Med. 1989, 87:89S-91S.
17. Hasselberg L., Grøsvik B.E., Goksøyr A., Celander M.C. Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comp. Hepatol. 2005, 4:2.
18. Hasselberg L., Westerberg S., Wassmur B., Celander M.C. Ketoconazole, an antifungal imidazole, increases the sensitivity of rainbow trout to 17 alpha-ethynylestradiol exposure. Aquat. Toxicol. 2008, 86:256-264.
19. Hegelund T., Ottosson K., Rådinger M., Tomberg P., Celander M.C. Effects of the antifungal imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish. Environ. Toxicol. Chem. 2004, 23:1326-1334.
20. Ho S.H., Cheng C.F., Wang W.S. Pharmacokinetics and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla). J. Vet. Sci. 1999, 61:459-463.
21. Hodson P.V., Qureshi K., Noble C.A., Akhtar P., Brown R.S. Inhibition of CYP1A enzymes by α-naphthoflavone causes both synergism and antagonism of retene toxicity to rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2007, 81:275-285.
22. Khan M.N., Reddy P.K., Renaud R.L., Leatherland J.F. Effect of cortisol on the metabolism of 17-hydroxyprogesterone by Arctic charr and rainbow trout embryos. Fish Physiol. Biochem. 1997, 16:197-209.
23. Kim J.H., Raisuddin S., Ki J.S., Lee J.S., Han K.N. Molecular cloning and beta-naphthoflavone-induced expression of a cytochrome P450 1A (CYP1A) gene from an anadromous river pufferfish, Takifugu obscurus. Mar. Pollut. Bull. 2008, 57:433-440.
24. Li D., Yang X.L., Zhang S.J., Lin M., Yu W.J., Hu K. Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): possible implications for the establishment of a fish CYP3A induction model. Comp. Biochem. Physiol. C 2008, 147:17-29.
25. Lister A., Regan C., Van Zwol J., Van Der Kraak G. Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat. Toxicol. 2009, 95:320-329.
26. Lin M., Yang X.L., Wang X.L., Fang W.H., Yu W.J. Enzymatic on deethlation metabolism of enrofloxacin in grass carp hepatocyte. High Technol. Lett. 2007, 17:314-318.
27. Lin M., Yang X.L., Fang W.H., Zhang N., Li D. Dose-response of inducers to effect on EROD in grass carp hepatocyte. J. Fish. China 2006, 30:311-315.
28. Lorenzana R.M., Hedstrom O.R., Buhler D.R. Localization of cytochrome P-450 in the head and trunk kidney of rainbow trout (Salmo gairdneri). Toxicol. Appl. Pharmacol. 1988, 96:159-167.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Biol. Chem. 1951, 193:265-275.
30. Martinsen B., Horsberg T.E. Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin and enrofloxacin in Atlantic salmon (Salmo salar) held in seawater at 10°C. Antimicrob. Agents Chemother. 1995, 39:1059-1064.
31. Moutou K.A., Burke M.D., Houlihan D.F. Hepatic P450 monooxygenase response in rainbow trout (Oncorhynchus mykiss (Walbaum)) administered aquaculture antibiotics. Fish. Physiol. Biochem. 1998, 18:97-106.
32. Park E.D., Lightner D.V., Stamm J.M., Bell T.A. Preliminary studies on the palatability, animal safety, and tissue residues of sarafloxacin-HCl in the penaeid shrimp, Penaeus vannamei. Aquaculture 1994, 126:231-241.
33. Pesonen M., Celander M., Förlin L., Andersson T. Comparison of xenobiotic biotransformation enzymes in kidney and liver of rainbow trout (Salmo gairdneri). Toxicol. Appl. Pharmacol. 1987, 91:75-84.
34. Plant N.J., Ogg M.S., Crowder M., Gibson G.G. Control and statistical analysis of in vitro reporter gene assays. Anal. Biochem. 2000, 278:170-174.
35. Riaz M.A., Poupardin R., Reynaud S., Strode C., Ranson H., David J.P. Impact of glyphosate and benzo[a]pyrene on the tolerance of mosquito larvae to chemical insecticides. Role of detoxification genes in response to xenobiotics. Aquat. Toxicol. 2009, 93:61-69.
36. Scott J.A., Hodson P.V. Evidence for multiple mechanisms of toxicity in larval rainbow trout (Oncorhynchus mykiss) co-treated with retene and α-naphthoflavone. Aquat. Toxicol. 2008, 88:200-206.
37. Snyder M.J. Cytochrome P450 enzymes in aquatic invertebrates: recent advances and future directions. Aquat. Toxicol. 2000, 48:529-547.
38. Sono M., Roach M.P., Coulter E.D., Dawson J.H. Heme-containing oxygenases. Chem. Rev. 1996, 96:2841-2888.
39. Tugnait M., Hawes E.M., McKay G., Eichelbaum M., Midha K.K. Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine. Hepatocyte Res. Rep. 1999, 118:171-189.
40. Tyrpenou A.E., Iossfidou E.G., Psomas I.E., Fotis G.D. Tissue distribution and depletion of sarafloxacin hydrochloride after in feed administration in gilthead seabream (Sparus aurata L.). Aquaculture 2003, 215:291-300.
41. Vaccaro E., Giorgi M., Longo V., Mengozzi G., Gervasi P.G. Inhibition of cytochrome P450 enzymes by enrofloxacin in the sea bass (Dicentrarchus labrax). Aquat. Toxicol. 2003, 62:27-33.
42. Wan X.Q., Ma T.W., Wu W.Z., Wang Z.G. EROD activities in a primary cell culture of grass carp (Ctenopharyngodon idellus) hepatocytes exposed to polychlorinated aromatic hydrocarbonas. Ecotoxicol. Environ. Saf. 2004, 58:84-89.
43. Wan X.Q., Wu W.Z., He J.Z. Evaluating toxic effects of PCDD/F using grass carp primary hepatocyte culture. China Environ. Sci. 2002, 22:114-117.
44. Wang X.L., Yang X.L., Zhang N., Yu W.J., Hu K. Induction of CYP2E1 activity in Ctenopharyngodon idellus hepatocyte. Acta Hydrobiol. Sin. 2008, 32:469-474.
45. Ward B.A., Morocho A., Kandil A., Galinsky R.E., Flockhart D.A., Desta Z. Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro. Br. J. Clin. Pharmacol. 2004, 58:277-287.
46. Wills L.P., Zhu S.Q., Willett K.L., Di Giulio R.T. Effect of CYP1A inhibition on the biotransformation of benzo[a]pyrene in two populations of Fundulus heteroclitus with different exposure histories. Aquat. Toxicol. 2009, 92:195-201.
47. Xia Z.L., Ying J.Y., Sheng R., Zeng S., Hu Y.Z., Yao T.W. In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method. J. Chromatogr. B: Analyt. Technol. Biomed Life Sci. 2007, 857:266-274.
48. Xu X., Liu H.Y., Liu L., Xie L., Liu X.D. The influence of a newly developed quinolone: antofloxacin, on CYP activity in rats. Eur. J. Drug Metab. Pharmacokinet. 2008, 33:1-7.
49. Yamauchi R., Ishibashi H., Hirano M., Mori T., Kim J.W., Arizono K. Effects of synthetic polycyclic musks on estrogen receptor, vitellogenin, pregnane X receptor, and cytochrome P450 3A gene expression in the livers of male medaka (Oryzias latipes). Aquat. Toxicol. 2008, 90:261-268.
50. Yoo H.H., Kim N.S., Lee J., Sohn D.R., Jin C., Kim D.H. Characterization of human cytochrome P450 enzymes involved in the biotransformation of eperisone. Xenobiotica 2009, 39:1-10.
51. Zhao P., Ragueneau-Majlessi I., Zhang L., Strong J.M., Reynolds K.S., Levy R.H., Thummel K.E., Huang S.M. Quantitative evaluation of pharmacokinetic inhibition of CYP3A substrates by ketoconazole: a simulation study. J. Clin. Pharmacol. 2009, 49:351-359.